Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$185.1 - $233.13 $171,772 - $216,344
928 New
928 $214,000
Q4 2017

Jan 17, 2018

SELL
$85.26 - $94.62 $37,514 - $41,632
-440 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$79.29 - $88.45 $34,887 - $38,918
440
440 $38,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $162B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Hirtle Callaghan & CO LLC Portfolio

Follow Hirtle Callaghan & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hirtle Callaghan & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hirtle Callaghan & CO LLC with notifications on news.